Brief: Immunovia Q2 Revenue SEK 85 Thousand
05/08/2024 07:30
Aug 05 (Reuters) - Immunovia Q2 adjusted free cash flow SEK -28.2 million. * Q2 adjusted EPS SEK -0.57 * Q2 net income SEK -25.6 million
Recent news on Immunovia AB (publ)
See all newsBrief: Immunovia Publishes Data On Pancreasure In Hereditary, Familial High-Risk Individuals
Brief: Immunovia To Carry Out Rights Issue Of About SEK 63 Million
Sweden's Immunovia Q2 sales rise on PancreaSure test uptake
Brief: Immunovia Reports Q2 Operating Loss Of SEK 22.8 Million
Brief: PancreaSure Achieves 88% Sensitivity In Immunovia Study